Combinational Therapy in Triple Negative Breast Cancer

Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at  the molecular level from a holistic approach, focusing on combinational  strategies targeting various pathways involved in this specific cancer  type. Using a monotherapy for the treatment of cancer, especially  high-grade tumors like TNBC, is mostly worthless due to the inherent  genetic instability of tumor cells to develop intrinsic and acquired  resistance. Combination therapy presents more, or at least the same,  effectiveness with lower doses of every single agent and decreases the  likelihood of chemoresistance, making it essential to understand for  multiple therapy options.

The book is a valuable resource for  cancer researchers, oncologists, graduate students and members of the  biomedical field who are interested in the potential of combinational  therapies to treat triple negative breast cancer.